Pro-Dex, Inc. (PDEX)
NASDAQ: PDEX · IEX Real-Time Price · USD
18.79
-0.29 (-1.52%)
Jul 26, 2024, 4:30 PM EDT - Market closed

Pro-Dex Revenue

Pro-Dex had revenue of $14.29M in the quarter ending March 31, 2024, with 9.28% growth. This brings the company's revenue in the last twelve months to $49.46M, up 2.90% year-over-year. In the fiscal year ending June 30, 2023, Pro-Dex had annual revenue of $46.09M with 9.62% growth.

Revenue (ttm)
$49.46M
Revenue Growth
+2.90%
P/S Ratio
1.31
Revenue / Employee
$338,753
Employees
146
Market Cap
64.24M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jun 30, 202346.09M4.05M9.62%
Jun 30, 202242.04M4.01M10.55%
Jun 30, 202138.03M3.20M9.17%
Jun 30, 202034.83M7.66M28.20%
Jun 30, 201927.17M4.71M20.95%
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro
Jun 30, 2015 Pro Pro Pro
Jun 30, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Theratechnologies 60.71M
Precision BioSciences 57.53M
Champions Oncology 50.16M
Gritstone bio 15.65M
Celularity 14.79M
Revenue Rankings